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Abstract
Background: Hypocalcemia caused by transient or definitive hypoparathyroidism is the most frequent
complication after total thyroidectomy (TT). We aimed to compare the impact of age and the clinical usefulness of
oral calcium and vitamin D supplements on postoperative hypocalcemia after TT, and to determine which risk
factors are important for hypocalcemia incidence.
Methods: Two hundred consecutive patients treated by TT were included prospectively in the present study. All
patients supplemented oral calcium and vitamin D in the post-operative time. The data concerning symptomatic
and laboratoristichypocalcemia were collected.
Patients were evaluated according to age, sex, postoperative serum calcium levels, and preoperative serum alkaline
phosphatasis levels.
Results: Symptomatic hypocalcemia developed only in 19 patients (9.5%), whereas laboratory hypocalcemia
developed in 36 patients (18%). The risk for postoperative hypocalcemia was increate 20-fold for patients older
than 50 years.
Conclusions: Age is significantly associated with postoperative hypocalcemia. Implementing oral calcium and
vitamin D after total thyroidectomy can reduce the incidence of hypocalcemia related to surgery.
Background
Total thyroidectomy (TT) is now the preferred option
for the management of benign multinodular goiter.
Postoperative hypocalcemia is observed in up to one
third of total or completion thyroidectomy patients and
is the most common complication, due to parathyroid
gland insufficiency, and it continues to challenge even
experienced surgeons since it often extends the duration
of hospital stay and increases the need for biochemical
tests [1-5]. Surgical technique has evolved to preserve
parathyroid function wherever possible. However,
transient hypoparathyroidism still occurs owing to para-
thyroid manipulation, devascularization, venous engor-
gement or inadvertent removal of the parathyroid
glands with the thyroid specimen.
Hypocalcemia after total thyroidectomy is usually transi-
ent, and the incidence of permanent hypoparathyroidism
is 3% or less according to the experience of most of the
surgical units studied [6-8]. Despite being self-limiting in
most patients, symptomatic hypocalcemia is of particular
concern because of a delay in its manifestation and the
consequent need for prolonged patient hospitalization or
readmission. Following total thyroidectomy, patients are
closely observed for bleeding in the first 24 h. The main
discharge-limiting factor thereafter is the development of
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hypocalcaemia as patients not at risk of hypocalcaemia
may be discharged on day 1 following surgery.
The causes of hypocalcemia after TT are multifactor-
ial, and some of these factors include iatrogenic surgical
trauma to the parathyroid glands, incidental parathyroi-
dectomy, the number of functioning glands left behind,
extent of surgery, experience of the surgeon, hyperthyr-
oidism, retrosternal goiter, concomitant neck dissection,
and thyroid carcinoma [9,10]. Several authors have
attempted to identify risk factors in the development of
hypocalcemia. Declines in serum calcium [7] or intact
parathyroid hormone (iPTH) levels [11,12] after surgery
have been suggested as being reliable predictors of post-
operative hypocalcemia. Although measurements of
serum calcium or iPTH allow the identification of
patients who have no risk of hypocalcemia after total
thyroidectomy, it is not always easy to predict which
patients can be discharged early from the hospital or to
identify those requiring close monitoring of serum cal-
cium levels or those that should receive calcium and
vitamin D supplements. Implementation of protocols
using postoperative PTH measurement has been shown
to facilitate day 1 discharge after thyroidectomy [13].
However, rapid PTH measurement is not readily avail-
able in many hospitals.
Routine oral calcium and vitamin D supplements have
been proposed to prevent the development of sympto-
matic hypocalcemia and to increase the likelihood of
early hospital discharge after bilateral surgical treatment
of the thyroid gland or exploration of the parathyroid
glands [14,15]. Vitamin D plays a critical role in calcium
homeostasis [16]. Insufficiency in calcium absorption
due to low vitamin D concentration leads to an increase
in parathyroid hormone (PTH) secretion. Increased
PTH stimulates the synthesis of calcitriol and thereby
improves calcium absorption efficiency. However, even
in patients who practiced a postoperative implementa-
tion with oral calcium and vitamin D, the risk of post-
operative hypocalcemic crisis is not avoided, suggesting
a role for other risk factors. Identifying some of this risk
factors can led, in turn, to a reduction in costs asso-
ciated with multiple blood samplings in monitoring the
development of hypocalcemia as well as costs associated
with prolonged hospitalization.
The aims of this prospective clinical study are: (1) to
compare the impact of age and the clinical usefulness of
oral calcium and vitamin D supplements on postopera-
tive hypocalcemia after TT, and (2) to determine which
risk factors are important for hypocalcemia incidence.
Methods
In the setting of a prospective study, 200 consecutive
patients [44 men (22%, mean age 45 ± 14 years), 156
women (78%, mean age 43±18 years)], undergoing total
thyroidectomy in the Division of General and Bariatric
Surgery at University of Naples S.U.N. between March
2011 and February 2013, were enrolled. All of the
patients had no history of prior thyroid or neck surgery.
Patients requiring unilateral lobectomy or subtotal or
completion thyroidectomy were excluded, and only
patients undergoing total thyroidectomy were enrolled
into the study. All patients had normal renal function at
the time of surgery. None of the patients had signs or
symptoms indicating metabolic bone disease, and none
of the patients were on medications, such as oral cal-
cium/ vitamin D supplementation, anti-resorptive
agents, hormone replacement therapy for postmenopau-
sal women, anabolic agents, thiazide type diuretics, or
antiepileptic agents, known to affect serum calcium
metabolism. Indications for surgery are listed in Table 1;
each subject provided a specific informed consent,
before being part of the study. The study plan was
reviewed and approved by local institutional ethical
committee.
The TT procedure consists of a 3- to 5-cm skin inci-
sion 1 to 1.5 cm above the sternal notch. After division
of the platysma, the cervical lineaalba is opened without
division of the strap muscles. The thyroid lobe is dis-
sected progressively from the strap muscles. After iden-
tification of the recurrent laringea nerve and parathyroid
glands, the vascular pedicles of the thyroid lobe are
ligated with the Harmonic Ace/Focus scalpel (Ethicon
Endo-Surgery Inc., Cincinnati, OH, USA), and the thyr-
oid lobe is removed [17-20]. After a check for hemosta-
sis, a drain is placed in the thyroid bed. The cervical
lineaalba and platysma are sutured with absorbable
sutures, and the skin is closed by an intracutaneous run-
ning suture.
Patients were asked to take oral calcium 2 g/d taken
twice (1 g every 12 hours) and vitamin D 1 g/d taken
twice (0.5 g every 12 hours) from the night of operation
to post-operative day 14. Intravenous calcium gluconate
was administered if significant symptomatic hypocalce-
mia persisted after surgery despite oral supplementation.
The medical and nursing notes were carefully exam-
ined for documentation of symptoms of hypocalcaemia.
The time of administration of calcium, vitamin D analo-
gues and intravenous fluids in relation to serum calcium
and hypocalcaemic symptoms was also noted. Serum
calcium, albumin, creatinine, and alkaline phosphatase
Table 1 Preoperative diagnosis
Disease TOTAL
N = 200
Multinodular goiter 168 (84%)
Carcinoma 20 (10%)
Basedow 12 (6%)
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levels were determined the day before surgery, on the
evening of surgery (’day 0’), on the morning of day 1
and then every 24 hours until patient discharge. Serum
calcium concentration was corrected for changes in
serum albumin. Serum calcium, creatinine, albumin, and
alkaline phosphatase were measured using automated
assays. The reference ranges for serum calcium in our
laboratory were 8.5 to 10.5 mg/dL.
All patients were seen in the outpatients department
2 weeks after surgery. The reported symptoms of hypo-
calcaemia and the treatment required to control these
symptoms were noted.
Postoperative hypocalcemia was defined as either
symptomatic or laboratory.
Hypocalcemic symptoms and signs, from perioral tin-
gling and numbness to carpopedal spasms and tetany, were
registered in detail. Laboratory hypocalcemia was defined
as serum total calcium concentrations of <8.0 mg/dL, even
if recorded only in a single measurement.
Statistics
Data were analyzed using SPSS 15.0 for Windows (SPSS
Inc, Chicago, IL). Results were expressed as mean ± SD.
Comparisons of data used the Wilcoxon signed-rank
test, chi-square test, and logistic regression analysis.
Results were considered statistically significant when the
2-tailed P value was less than 0.05.
Results
All patients respected the oral supplement protocol. The
thyroid diseases of the patients included in the study are
shown in Table 1. The operative procedures were all
total thyroidectomy. No major complication occurred
(e.g. persistent vocal cord paralysis and hypoparathyroid-
ism, bleeding requiring reintervention). Incidental para-
thyroidectomy was found in 3 patients (1.5%).
The means (±SD) for serum albumin, creatinine, cal-
cium and alkaline phosphatase levels were 3.8 ± 0.09 g/dL,
0.8 ± 0.1 mg/dL, 8.9 ± 0.2 mg/dl, and 162 ± 74 U/L,
respectively. The postoperative serum calcium level was
lower than the preoperative serum calcium level (8.9 ±
0.2 mg/dLvs 8.2 ± 0.9 mg/dL, P < 0.001).
Symptomatic hypocalcemia developed only in 19
patients (9.5%), whereas laboratory hypocalcemia devel-
oped in 36 patients (18%). Hypocalcemic symptoms were
minimal in 12 patients. Intravenous calcium was adminis-
tered to 7 patients with severe hypocalcemic symptoms
(Table 2). Regarding these latter cases only, in the subse-
quent hystopathological analysis on removed thyroid tis-
sue, incidental parathyroid tissues were found in three.
Permanent hypocalcemia developed in none of patients.
Hypercalcemia or other side effects did not develop in any
of the patients receiving routine oral supplements.
Age and serum alkaline phosphatase levels were signifi-
cantly higher in patients who developed hypocalcemia
than in others (56.7 ± 8 years and 242.21 ± 72 U/L vs
42.1 ± 9 years and 123.21 ± 41 U/L, P < 0.001). Postopera-
tive serum calcium levels were significantly lower in hypo-
calcemic patients (7.3 ± 0.4 mg/dLvs 8.6 ± 0.3 mg/dL,
P < 0.001).
Hospital stay was significantly longer in hypocalcemic
patients (4 ± 1 days, range 2-5 days) than others (2 ±
0.5 days, range 1-3 days) (P < 0.001). In female patients,
the ratio of postoperative hypocalcemia was found to be
significantly higher when compared to male patients
(24% vs 8%, P < 0.01).
There was a negative correlation between serum cal-
cium level and age (rs- 0.501, P < 0.001) and female
gender (rs- 0.203, P < 0.01) and serum alkaline phospha-
tase level (rs-0.498, P < 0.001).
Patient age and preoperative serum alkaline phospha-
tase level, were independent significant variables in the
development of hypocalcemia after thyroidectomy. The
risk for postoperative hypocalcemia was increased 20-
fold for patients older than 50 years (odds ratio [OR]
20.2; 95% confidence interval [CI] 10.4- 58.3).
Discussion
The present study shows that post-operative oral cal-
cium and vitamin D supplements can reduce the inci-
dence of hypocalcemia after total thyroidectomy. Also,
we investigated the prediction value of age, preoperative
serum calcium and alkaline phosphatase on postopera-
tive hypocalcemia after total thyroidectomy.
We found that age was significantly associated with
postoperative hypocalcemia. Negative correlations were
observed between the serum calcium level and age, and
serum alkaline phosphatase level. According to a logistic
regression analysis, age was a significant independent
variable associated with postoperative hypocalcemia.
Postoperative hypocalcemia is one of the most fre-
quent complications after TT [21]. In several studies,
the incidence of hypoparathyroidism varied from 1.6%
to above 50% [7,22].
The causes of hypocalcemia after TT are multifactorial,
and some of these causes include injury, devascularization,
and unintentional excision of parathyroid glands, the
number of functioning glands left behind, the extent of
surgery, the experience of the surgeon, hyperthyroidism,
Table 2 Patients developing hypocalcemia
Hypocalcemia Total N = 200
LaboratoryHypocalcemia 36 (18%)
SymptomaticHypocalcemia 19 (9.5%)
Requiring E.V. Calcium 7 (3.5%)
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retrosternal goiter, concomitant neck dissection, and thyr-
oid carcinoma [22-27].
However, the role of implementation of oral calcium
and vitamin D is not new, and it is considered an effec-
tive approach to the prevention of hypocalcemia.
Infact, this treatment prevented a significant decrease
of serum calcium levels as well as the subsequent devel-
opment of major hypocalcemic symptoms after total
thyroidectomy. The symptoms reported by patients were
minimal and only seven required intravenous calcium
administration after his persistent significant hypocalce-
mia failed to respond to implementation of oral calcium
and vitamin D. However, in this case hypocalcemic sta-
tus was probably due to the accidental removal of para-
thyroid tissue during surgery, as shown by hystological
analysis.
Two studies have evaluated the efficacy of routine cal-
cium supplements for the prevention of hypocalcemia
after thyroidectomy [28,29]. Moore [28] reported that
only 4 of 124 patients who received daily treatment of
calcium (5 g) after bilateral thyroid resection developed
hypocalcemia, and 1 required administration of intrave-
nous calcium. Based on empirical observations, the pro-
phylactic use of oral calcium to reduce the risk of
hypocalcemic crisis and increase the likelihood of early
hospital discharge was recommended. Bellantone et al
[29] reported in a prospective control study that only 3
of 26 patients (11%) receiving oral calcium supplement
(3 g/d) had symptoms related to hypocalcemia after
total thyroidectomy, whereas 11 of 27 patients (40%) not
receiving calcium supplement had symptoms. These stu-
dies suggest that postthyroidectomyhypocalcemia can be
considerably prevented by the routine administration of
calcium supplements.
The risk for postoperative hypocalcemia for patients
undergoing TT was higher than that for patients with
advanced age.
Recently, there has been a great deal of interest in
identifying perioperative factors that can predict the
development of hypocalcemia after thyroidectomy
[30,31]. The drive towards a shorter hospital stay follow-
ing total thyroidectomy has led to a number of studies
evaluating the use of plasma biochemical markers to
predict the development of hypocalcaemia. Thyroid sur-
gery impairs PTH secretion by the parathyroid glands
resulting in postoperative parathyroid insufficiency and
subsequent development of hypocalcaemia [32]. The
measurement of serum calcium concentration following
thyroidectomy has been used in an attempt to predict
the development of hypocalcaemia. However, the mea-
surement of total serum calcium is inaccurate, at least
in part, owing to postoperative haemodilution [33,34].
The value of PTH in predicting post-thyroidectomy
hypocalcemia has been extensively investigated and
reported in the literature [35,36] Although the use of
PTH post-thyroidectomy may allow shorter hospital
admission, rapid access to results of postop- erative
PTH measurement is not widely available in most hospi-
tals. In addition, there is no consensus on the threshold
for PTH and the optimal timing for its measurement
post-thyroidectomy. The PTH measurement on the first
postoperative day has been shown to be a useful method
to predict post-thyroidectomy hypocalcemia [37]. Serum
PTH concentration, when checked 1-6 h after thyroi-
dectomy, has a higher accuracy in predicting hypocal-
caemia [38]. Whilst the use of serum PTH levels to
predict post-thyroidectomy hypocalcaemia is well estab-
lished, it appears to lack the desirable 100% accuracy
rate. We were not able to analyse the postoperative per-
centage decline in PTH owing to the lack of preopera-
tive PTH data. However, both absolute levels and
percentage decline have been used to predict hypocal-
caemia with similar accuracy, and, although similar,
levels vary between institutions [36].
Also, we think that post-operative hypocalcemia can
be reduced when a precise minimal surgical dissection is
performed; in fact, the use of harmonic scalpel can help
to avoid energy spread, blood loss and edema, thus lim-
iting parathyroid function impairment [17-20].
Vitamin D has a critical role in calcium homeostasis.
Vitamin D deficiency has been frequently documented
in medically ill and free-living populations [39,40]
Advanced age is reported to be a major risk factor for
vitamin D deficiency. Aging is associated with altera-
tions in vitamin D metabolism. Studies have observed
(1) an age-related decrease in renal 1-hydroxylase activ-
ity and intestinal calcium absorption, and (2) an age-
related decline in the cutaneous accumulation of
7-dehydrocholesterol, which is converted into previta-
min-D3 by solar ultraviolet radiation. Insufficient cal-
cium absorption due to low vitamin D concentrations
leads to an increase in PTH secretion. Increased PTH
stimulates the synthesis of calcitriol and thereby
improves calcium absorption efficiency [39,40].
In previous studies, regimens of oral calcium alone
and of a calcium and vitamin D combination were effec-
tive. The study from Bellantone et Al [29] also revealed
that the addition of vitamin D to oral calcium supple-
ments was associated with significantly higher serum
calcium concentrations on post- operative days 2 and 3
and with a lower incidence of hypocalcemia. Although it
has been reported that vitamin D administration inhibits
iPTH secretion by normally functioning parathyroid
glands, prior studies and our own results showed that
iPTH secretion was not affected by vitamin D adminis-
tration in postthyroidectomy patients. Therefore, the
early use of vitamin D in addition to calcium supple-
ments can be recommended for patients undergoing
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total thyroidectomy. The dosages and durations of cal-
cium and vitamin D administration are also of concern.
In a study from Roh and Park [32], routine oral calcium
and vitamin D supplements were effective in reducing
the incidence (6%) and severity of hypocalcemia after
total thyroidectomy. Only a minority of patients receiv-
ing the supplements presented with minimal symptoms
related to hypocalcemia, and higher levels of serum cal-
cium during the first few days after total thyroidectomy
were measured in patients receiving the supplement.
In a previous study, we also documented that regi-
mens of oral calcium alone and of a calcium and vita-
min D combination were effective in most cases of
thyroidectomy performed for benign thyrodeal pathol-
ogy [41-44].
Conclusions
The prevention of significant symptomatic hypocalcemia
will allow early discharge of postthyroidectomy patients
from the hospital. In turn, early discharge eliminates the
necessity of multiple blood samplings for close monitor-
ing of serum calcium or iPTH levels. However, the risk
of postoperative hypocalcemia for patients undergoing
TT was higher than that for patients with advanced age.
In these patients, an accurate clinical and laboratoristic
follow up during the post-operative period is necessary.
In conclusion, our data suggest that postoperative oral
calcium and vitamin D supplements can take a role the
prevention of postoperative hypocalcemia and for
increasing the likelihood of a safe and early discharge
from the hospital.
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